Novel compositions and methods for treating ige-mediated disorders

摘要

The present disclosure relates to immunoglobulins that bind IgE and Fc³RIIb with high affinity, said compositions comprising said immunoglobulins being capable of inhibiting cells that express membrane-anchored IgE. Such compositions are useful for treating IgE-mediated disorders, including allergies and asthma.